Core Points - The company has established a management system for entrusted financial management to enhance risk control and investment returns while safeguarding the interests of the company and its shareholders [1][2] - The entrusted financial management is defined as the act of entrusting financial institutions to invest idle funds under the premise of risk control, focusing on capital preservation and increasing cash asset returns [1][2] - The company emphasizes compliance with relevant laws and regulations, ensuring that entrusted financial management does not affect its normal operations and main business development [1][2] Summary by Sections General Principles - The entrusted financial management must be based on idle self-owned funds and cannot use raised funds or affect normal operational and project construction funds [2] - The management system applies to the company and its subsidiaries, requiring prior approval for any entrusted financial activities by management and board members [2] Approval Authority and Decision-Making Procedures - For entrusted financial amounts reaching or exceeding 50% of the latest audited net assets within 12 months, the financial department is responsible for feasibility analysis and risk assessment, followed by board and shareholder approval [2][3] - For amounts not exceeding 50% of the latest audited net assets, the same approval process applies, but without the need for shareholder approval [3] Daily Management and Reporting System - The financial department is responsible for daily management, including risk assessment, selection of qualified financial institutions, and monitoring of investment performance [4][5] - Regular reporting to the board is required after signing entrusted financial agreements and monthly updates on the status of financial products [5] Risk Control and Information Disclosure - The internal audit department supervises the entrusted financial management, ensuring regular audits of progress, profit and loss, and risk control [6] - Independent directors and the audit committee have the authority to inspect the entrusted financial management situation [6] Miscellaneous - The management system will be revised and interpreted by the board, and it becomes effective upon board approval [7]

Group 1 - The company announced plans to use up to 200 million yuan of idle funds for entrusted wealth management [2] - The investment will focus on medium to low-risk financial products such as structured deposits, income certificates, funds, and bonds [2]

Core Viewpoint - The company has established a management system for entrusted financial management to enhance the efficiency of idle funds, increase cash asset returns, and ensure the safety of company assets while complying with relevant laws and regulations [1][2]. Group 1: General Principles - The entrusted financial management refers to the operation and management of idle funds through financial institutions to achieve capital preservation and appreciation while ensuring safety and liquidity [2]. - The company adheres to principles of standardized operations, risk prevention, cautious investment, and capital preservation, ensuring that entrusted financial management does not affect normal operations and business development [2]. - Funds for entrusted financial management must come from idle funds and should not encroach on operational or project construction funds [2]. Group 2: Approval Authority and Execution Procedures - If the entrusted financial management amount exceeds 10% of the latest audited net assets and is over 10 million RMB, it must be approved by the board of directors and disclosed in a timely manner [3]. - The financial center is responsible for the preliminary demonstration of entrusted financial management plans, including feasibility analysis and risk assessment of the entrusted party [4]. - The approval process for entrusted financial management involves risk assessment and feasibility analysis, followed by reporting to the decision-making body for approval [4]. Group 3: Daily Management and Reporting System - The financial center manages the entrusted financial management business, including preparing annual plans and conducting daily management and financial accounting [5]. - Monthly reports on entrusted financial management must be submitted to the financial responsible person within 10 days after the end of each month [5]. Group 4: Risk Control and Information Disclosure - The internal audit department supervises entrusted financial management, conducting audits and checks on the use of funds and operational conditions [6]. - The board of directors must ensure that risk control measures are effective and that the entrusted party has a good credit record and financial status [6]. - The company must disclose entrusted financial management matters according to the regulations of the Shenzhen Stock Exchange, including the purpose, amount, and risk control measures [7][8].

Core Points - The company held its fifth board meeting on August 20, 2025, where several key resolutions were passed, including the approval of the 2025 semi-annual report and proposals for bank credit applications and gold leasing business [1][2][3] Group 1: Financial Reports - The board approved the 2025 semi-annual report, which was reviewed by the audit committee and received unanimous support from all attending directors [1] Group 2: Bank Credit and Gold Leasing - The company plans to apply for a total credit limit of up to 1.1 billion yuan from various banks, including 60 million yuan from Jiangsu Bank and 50 million yuan each from Ningbo Bank and Industrial Bank, to support business development and daily operations [1][2] - Within this credit limit, the maximum amount for gold leasing transactions is set at 200 million yuan, equivalent to approximately 250 kilograms of gold, with a rolling usage period from September 1, 2025, to August 31, 2026 [2] Group 3: Investment and Management Policies - The board approved the use of self-owned funds for entrusted wealth management, with details disclosed in a separate announcement [2] - Several internal management systems are to be revised to enhance governance and risk control, including the management of shares held by directors and executives, independent director work systems, and related party transaction management [3]

Core Viewpoint - The company has established a set of regulations for entrusted financial management to enhance fund operation efficiency, ensure asset safety, and mitigate investment risks while protecting the rights of shareholders and the company [1]. Chapter Summaries Chapter 1: General Principles - The regulations aim to standardize the company's entrusted financial management activities and apply to the company and its subsidiaries, requiring approval for any entrusted financial activities [1][2]. Chapter 2: Management Principles - The company must adhere to principles of standardized operations, risk prevention, cautious investment, and value preservation while ensuring that financial products align with the company's funding plans [4][5]. - Funds used for entrusted financial management must come from idle self-owned funds or idle raised funds, without affecting normal operations or project funding [2][3]. Chapter 3: Approval Authority and Implementation - The approval process for entrusted financial management varies based on the amount, with specific thresholds for managerial and board approvals [3][4]. - The company can estimate the scope, amount, and duration of entrusted financial management for the next twelve months to streamline operations [3]. Chapter 4: Business Supervision and Risk Control - The company must sign written contracts with trustees, specifying the amount, duration, investment types, and responsibilities to mitigate risks [5][6]. - The finance center is responsible for managing entrusted financial accounts and ensuring all transactions are conducted in the company's name [5][6]. Chapter 5: Accounting Management - Upon completion of entrusted financial management, the company must obtain investment certificates and maintain proper accounting records [6]. Chapter 6: Information Disclosure and Accountability - The company is required to disclose relevant information regarding entrusted financial management in accordance with laws and regulations [7]. - Specific situations, such as failure to raise funds or significant risks to the trustee, must be disclosed promptly [7]. Chapter 7: Supplementary Provisions - The regulations take effect upon approval by the board and are subject to relevant laws and regulations [8].

（一）公司委托理财业务应坚持"规范运作、防范风险、谨慎投资、保值 增值"的原则，以不影响公司正常经营和主营业务的发展为先决条件； （二）委托理财的资金为公司闲置资金（包括闲置的自有资金和暂时闲置 的募集资金），不得挤占公司正常运营和项目建设资金，不得影响募集资金项 目使用进度，公司使用暂时闲置募集资金开展现金管理业务的，应当遵照公司 《募集资金管理制度》以及证券交易所的相关规定执行； （三）暂时闲置的募集资金可进行现金管理，其投资的产品须符合以下条 件： 产品专用结算账户（如适用）不得存放非募集资金或用作其他用途，开立或注 销产品专用结算账户的，公司应当及时报证券交易所备案并公告。 哈尔滨敷尔佳科技股份有限公司 第一章 总则 第一条 为规范哈尔滨敷尔佳科技股份有限公司（以下简称"公司"）委 托理财行为，保证公司资产安全，有效控制投资风险，提高投资收益，维护公 司及股东合法权益，依据《中华人民共和国证券法》《深圳证券交易所创业板 股票上市规则》《深圳证券交易所上市公司自律监管指引第7号——交易与关联 交易》及《哈尔滨敷尔佳科技股份有限公司章程》（以下简称"《公司章 程》"）等相关规定，制定本制度。 第二条 本制 ...

Core Viewpoint - The company, Jiangsu Hengrui Medicine Co., Ltd., has announced its 2025 semi-annual report and several key resolutions from its board and supervisory meetings, including the establishment of an employee stock ownership plan and the appointment of an external audit firm for the fiscal year 2025 [5][28][17]. Group 1: Company Overview - Jiangsu Hengrui Medicine Co., Ltd. is engaged in the pharmaceutical industry, focusing on the development and production of innovative drugs [3]. - The company has a total of 364,655 ordinary shareholders, with 364,643 being A-share holders and 12 being H-share holders as of the end of the reporting period [3]. Group 2: Financial Data - The company has not disclosed specific financial data in the provided documents, but it emphasizes the importance of reviewing the full semi-annual report for comprehensive financial insights [1][2]. Group 3: Important Resolutions - The board of directors approved the 2025 semi-annual report and the employee stock ownership plan draft, which aims to enhance employee motivation and company competitiveness [28][29]. - The company plans to use up to RMB 60 billion of its idle funds for entrusted wealth management to improve the efficiency of fund utilization [42][44]. - The company intends to repurchase its A-shares with a total fund amount between RMB 10 billion and RMB 20 billion, aimed at supporting the employee stock ownership plan [56][61]. Group 4: Audit and Compliance - The company has proposed to appoint Ernst & Young as its external auditor for the fiscal year 2025, pending approval from the shareholders' meeting [17][22]. - The board and supervisory committee have confirmed that the report and resolutions comply with relevant laws and regulations, ensuring the accuracy and completeness of the information provided [6][25].

Core Viewpoint - The company has decided to utilize idle raised funds for wealth management to enhance the efficiency of fund usage and maximize shareholder returns [3][12]. Investment Overview - The company is using idle raised funds amounting to 20 million yuan for cash management, ensuring the normal implementation of fundraising projects and the safety of funds [4][3]. - The funds were raised through a non-public offering of 37,827,586 shares at a price of 15.36 yuan per share, totaling approximately 581 million yuan, with a net amount of about 570 million yuan after deducting issuance costs [4]. Investment Method - The company will invest the idle funds of 20 million yuan through a large-denomination deposit business with China Minsheng Bank [5]. - The redemption mechanism allows the company to redeem the investment after one month, ensuring flexibility based on funding needs [6]. Approval Process - The investment plan was approved at the sixth meeting of the ninth board of directors on April 15, 2025, and subsequently ratified at the annual shareholders' meeting on June 24, 2025 [7]. Financial Impact - As of June 30, 2025, the company's debt-to-asset ratio was 29%, and the investment of 20 million yuan in large-denomination deposits will not significantly impact the company's main operations or financial status [11]. - The use of idle funds for wealth management is expected to improve fund utilization efficiency and generate investment returns for shareholders without harming the company's interests [12]. Intermediary Opinions - The company's sponsor, CITIC Securities, confirmed that the use of idle raised funds for cash management complies with relevant regulations and does not affect the company's daily operations or change the intended use of the raised funds [13].

8月20日晚间，恒瑞医药（600276.SH）发布半年报。财报显示，2025年上半年，恒瑞医药实现营收 157.6亿元，同比增长15.9%；实现归母净利润44.5亿元，同比增长29.7%；扣非归母净利润为42.7亿元， 同比增长22.4%。 创新药销售占比超六成 记者注意到，恒瑞医药在2025年上半年维持了较高的研发投入：报告期内，公司累计研发投入达38.71 亿元，其中费用化研发投入为32.28亿元。 对此，恒瑞医药在半年报中表示，该公司的经营业务变化主要集中在创新药销售收入上；公司在报告期 内收到Merck Sharp & Dohme 2亿美元及IDEAYA 7500万美元的对外许可首付款，并确认为收入，对利 润的增加产生了显著影响。 数据显示，2025年上半年，恒瑞医药的创新药业务销售引领业绩增长，创新药销售及许可收入为95.61 亿元，占公司营业收入的比重达60.66%；其中，创新药销售收入达75.70亿元。 拟回购10亿至20亿股股份 8月20日，恒瑞医药收报62.85元/股，总市值达4171.48亿元。 截至二季度末，恒瑞医药总资产为628.94亿元，较上年度末增长25.4%；归母净资产为584. ...

【导读】 " 药茅 " 恒瑞医药 "豪掷"60亿买理财，上半年净利增长近三成 见习记者 许梦旖 8月20日晚间，恒瑞医药（600276.SH）发布半年报。财报显示，2025年上半年，恒瑞医药实现营收157.6亿元，同比 增长 15.9%；实 现归母净利润44.5亿元，同比 增长 29.7%；扣非归母净利润为42.7亿元，同比 增长 22.4%。 创新药销售占比超六成 记者注意到，恒瑞医药在2025年上半年维持了较高的研发投入：报告期内，公司累计研发投入 达 38.71亿元，其中费用化研发投入 为 32.28亿元。 对此，恒瑞医药在半年报中表示，该公司的经营业务变化主要集中在创新药销售收入上；公司在报告期内收到Merck Sharp & Dohme 2亿 美元及IDEAYA 7500万美元的对外许可首付款 ，并 确认为收入，对利润的增加产生了显著影响。 数据显示，2025年上半年，恒瑞医药的创新药业务销售引领业绩增长，创新药销售及许可收入为95.61亿元，占公司营业收入 的 比重 达 60.66%；其中，创新药销售收入达75.70亿元。 拟回购 10亿至20亿股 股份 同时，恒瑞医药发布《关于以自有闲置资金进行 ...